Natasha Hernday

CIK 1780547 · last filed 2026-05-26

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$220.3K

Companies

5

Total Filings

19

Lifetime Open-Market Net

$0

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
XOMAP Director 4,000 $25.46 $101.9K $0 7 2026-05-26
JANX Director 8,731 $13.56 $118.4K $0 3 2025-06-13
ALPINE IMMUNE SCIENCES, INC. (ALPN) Delisted Director $64.97 $0 6 2024-05-20
PDL BIOPHARMA, INC. (PDLI) Delisted Director 75,826 $0 2 2020-08-24
XOMA Director $41.79 $0 1 2020-07-02

Recent Filings · Page 2 of 2

19 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2022-05-20 XOMAP Grant (A) $0 EDGAR
2022-01-04 ALPINE IMMUNE SCIENCES, INC. (ALPN) Delisted Grant (A) $0 EDGAR
2021-05-21 XOMAP Grant (A) $0 EDGAR
2021-01-05 ALPINE IMMUNE SCIENCES, INC. (ALPN) Delisted Grant (A) $0 EDGAR
2020-12-17 XOMAP Grant (A) +4,000 $100.0K EDGAR
2020-12-11 ALPINE IMMUNE SCIENCES, INC. (ALPN) Delisted Grant (A) $0 EDGAR
2020-08-24 PDL BIOPHARMA, INC. (PDLI) Delisted Grant (A) +25,826 $0 EDGAR
2020-07-02 XOMA Grant (A) $0 EDGAR
2019-06-24 PDL BIOPHARMA, INC. (PDLI) Delisted Grant (A) +50,000 $0 EDGAR
Showing 1119 of 19
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.